Clinical Trial Starts for Inhaled COVID-19 Treatment
According to The Week, the new drug has been shown to reduce the odds of COVID-19 patients developing severe symptoms by an impressive 80% in a phase 2 trial of 100 patients. The phase 3 trial, which begins this week, has over 600 volunteers in 20 countries...
Source: newsmax.com